ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 790,26
1,44%
DAX
18 518,03
-0,44%
Brent Oil
83,475
-1,03%
Bitcoin
64 481,12
-0,57%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
27/07/202114h00PR Newswire (US)Insmed to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021NASDAQ:INSMInsmed Inc
09/07/202122h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
09/07/202122h50Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
08/07/202114h00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
22/06/202112h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
25/05/202113h00PR Newswire (US)Insmed To Present at Two June ConferencesNASDAQ:INSMInsmed Inc
19/05/202123h31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INSMInsmed Inc
19/05/202122h05PR Newswire (US)Insmed Presents Broad Range of Data Across Its Three Programs at the American Thoracic Society 2021 International ConferenceNASDAQ:INSMInsmed Inc
13/05/202117h14PR Newswire (US)Insmed Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes and Full Exercise of Underwriters' ...NASDAQ:INSMInsmed Inc
12/05/202112h07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:INSMInsmed Inc
11/05/202107h54PR Newswire (US)Insmed Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028NASDAQ:INSMInsmed Inc
10/05/202113h00PR Newswire (US)Insmed Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028NASDAQ:INSMInsmed Inc
06/05/202113h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
06/05/202113h30PR Newswire (US)Insmed Reports First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
22/04/202114h00PR Newswire (US)Insmed to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 6, 2021NASDAQ:INSMInsmed Inc
12/04/202119h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
01/04/202122h30Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
29/03/202119h26Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:INSMInsmed Inc
23/03/202110h00PR Newswire (US)ARIKAYCE® (amikacin liposome inhalation suspension) Approved by Japan's Ministry of Health, Labour and Welfare for the Treat...NASDAQ:INSMInsmed Inc
25/02/202113h30PR Newswire (US)Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
24/02/202114h00PR Newswire (US)Insmed to Present at Two March ConferencesNASDAQ:INSMInsmed Inc
19/02/202113h30PR Newswire (US)Insmed Announces Topline Results from Phase 1 Study of Treprostinil Palmitil Inhalation Powder (TPIP)NASDAQ:INSMInsmed Inc
16/02/202114h00PR Newswire (US)Insmed to Host Conference Call to Discuss Topline Data from Treprostinil Palmitil Inhalation Powder Phase 1 StudyNASDAQ:INSMInsmed Inc
12/02/202114h00PR Newswire (US)Insmed to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021NASDAQ:INSMInsmed Inc
05/01/202114h00PR Newswire (US)Insmed to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:INSMInsmed Inc
04/01/202114h00PR Newswire (US)Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with M...NASDAQ:INSMInsmed Inc
02/12/202014h00PR Newswire (US)Insmed Announces Initiation of Phase 3 ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
24/11/202014h00PR Newswire (US)Insmed to Present at the Evercore ISI 3rd Annual HealthCONx ConferenceNASDAQ:INSMInsmed Inc
13/11/202014h00PR Newswire (US)Insmed Receives Priority Medicines (PRIME) Designation from European Medicines Agency (EMA) for Brensocatib in Patients with ...NASDAQ:INSMInsmed Inc
02/11/202014h00PR Newswire (US)Insmed to Present at Two November ConferencesNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
PX1
CAC 40
EU
LR
Legrand
EU
EN
Bouygues
EU
AF
Air FranceKLM
NYSE
JPM
JP Morgan Chase
EU
ORA
Orange
COIN
ETHUSD
Ethereum
EU
CAP
Capgemini
EU
RI
Pernod Ricard
EU
BNP
BNP Paribas
EU
CS
Axa
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés